James Peyer, Cambrian CEO

Brent Saun­ders joins $100M Se­ries C for a com­pa­ny out to be the Bridge­Bio of ag­ing

About a year ago, James Pey­er, a CEO and co-founder of the lit­tle known longevi­ty biotech Cam­bri­an Bio­phar­ma, was try­ing to find some R&D tal­ent …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.